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Background: Inverse associations between risk factors and mortality have been reported in 
epidemiological studies of patients on maintenance hemodialysis (MHD).
Objective: The aim of this prospective study was to estimate the effect of the dual variable 
pulse pressure (PP) – body mass index (BMI) on cardiovascular (CV) events and death in type 2 
diabetic (T2D) subjects on MHD in a Caribbean population.
Methods: Eighty Afro-Caribbean T2D patients on MHD were studied prospectively from 2003 
to 2006. Proportional-hazard modeling was used.
Results: Of all, 23.8% had a high PP (PP  75th percentile), 76.3% had BMI  30 Kg/m2, 
21.3% had the dual factor high PP – absence of obesity. During the study period, 23 patients 
died and 13 CV events occurred. In the presence of the dual variable and after adjustment for 
age, gender, duration of MHD, and pre-existing CV complications, the adjusted hazard ratio 
(HR) (95% CI) of CV events and death were respectively 2.7 (0.8–8.3); P = 0.09 and 2.4 
(1.1–5.9); P = 0.04.
Conclusions: The dual factor, high PP – absence of obesity, is a prognosis factor of outcome. 
In type 2 diabetics on MHD, a speciﬁ  c management strategy should be proposed in nonobese 
subjects with wide pulse pressure in order to decrease or prevent the incidence of fatal and 
nonfatal events.
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Introduction
Type 2 diabetes (T2D) is a rapidly growing health problem in Guadeloupe and is highly 
prevalent in patients on maintenance hemodialysis (MHD) as found in countries with 
a western lifestyle (Foucan et al 2000).
Traditional risk factors of cardiovascular disease (CVD) in the general population, 
such as hypertension, obesity, and hypercholesterolemia, were previously associated 
with better survival on dialysis (Kalantar-Zadeh et al 2005; Nurmohamed 2005). This 
inverse association between clinical risk factors and mortality has been reported in 
several epidemiological studies of dialysis patients (Kalantar-Zadeh et al 2003, 2005; 
Kopple 2005). Thus, in subjects on MHD, weight gain and baseline obesity have been 
associated with a reduced cardiovascular risk with a lowest mortality in morbidly obese 
patients (Kalantar-Zadeh et al 2005). Hypertension is a common co-morbid condition 
in dialysis patients. In diabetic patients with chronic kidney disease, the blood pressure 
treatment goal is less than 130/80 mmHg (Chobanian et al 2003; Prisant 2003). But, in 
patients on MHD, the hypertension contribution to a poor prognosis is controversial. 
A time effect is evocated with a high risk of early mortality for hypotension and a Vascular Health and Risk Management 2008:4(6) 1402
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high risk of late mortality for hypertension (Zager et al 1998; 
Charra 2007). Some authors reported that pulse pressure (PP), 
an indicator of arterial stiffness (Nawrot et al 2004), was 
an independent predictor of total mortality in nondiabetic 
patients on MHD (Tozawa et al 2002). Some others, in a clini-
cal review, highlighted the potential dangers of extrapolating 
trials ﬁ  ndings from nonkidney disease patients to those with 
chronic kidney disease (Kaisar et al 2007).
Studies of patients on MHD are more often conducted 
on overall populations with diabetes status considered as 
a covariate. Further more to our knowledge, the prognosis 
signiﬁ  cance of the dual factor body mass index (BMI) – PP 
has not yet been reported in T2D subjects undergoing HD.
The present study was conducted in Guadeloupe, a French 
Caribbean island of 420,000 inhabitants. On this island, about 
30% of the 400 individuals receiving renal replacement 
therapy are diabetics and the majority of them have T2D.
We hypothesized that the combination of a BMI less 
than 30 kg/m2 and a wide pulse pressure at baseline are 
independently associated with cardiovascular (CV) events 
and total mortality in T2D patients undergoing hemodialysis 
with a higher risk for this dual factor than for each of them 
considered separately.
Patients and method
A longitudinal study was conducted in Guadeloupe during 
the period of December 2003 through December 2006.
Study population
The study population was constituted of subjects alive on 
December 2003, and who had been treated for more than 
one month in dialysis. They were 33 to 80-years-old and 
were selected in 3 dialysis centers of the island. Dialysis was 
performed three times per week. The diabetic status was a 
co-morbid condition or an etiology of chronic kidney disease. 
The sample represented nearly 85% of the T2D patients on 
HD in the island and was previously described in a cross 
sectional study at baseline (Foucan et al 2005).
Data collection
Demographic, clinical and laboratory data were collected on 
all T2D patients on dialysis on December 2003 and dialyzed 
for more than 1 month. Data collected were: age, gender, 
years on chronic HD prior to December 2003, history of 
disease (hypertension, stroke, and coronary disease), use of 
current antidiabetic and antihypertensive treatment.
Height, weight were measured. The BMI, weight/height2 
(kg/m2) was calculated.
Blood pressure
We have taken into account systolic (SBP) and diastolic 
blood pressure (DBP) recorded at baseline with an auto-
mated method before HD for every single observed HD. 
The retained values were the average systolic and average 
diastolic pressures over a month period.
Deﬁ  nition of clinical factors 
and outcome data
Pulse pressure was calculated as SBP – DBP (mmHg). High 
pulse pressure corresponded to a PP equal or higher than the 
75th percentile of the overall PP values for each gender.
Hypertension was deﬁ  ned as a SBP  140 or a DBP  
90 mmHg or history of hypertension and current use of 
antihypertensive medication.
Obesity was deﬁ  ned as BMI  30 kg/m2 and morbid 
obesity as BMI  40 kg/m2.
The dual factor was deﬁ  ned as the following combination: 
PP  75th percentile – BMI  30 kg/m2.
Outcome data were obtained from medical record. Car-
diovascular events included coronary artery disease (angina 
pectoris, acute myocardial infarction, coronary bypass sur-
gery, or coronary angioplasty), stroke and death related to 
CV events. Cardiovascular death was deﬁ  ned as death from 
coronary disease or stroke.
Pre-existing CV complications included cardiac events 
(coronary event and stroke) occurred before December 2003.
All patients were followed up until coronary events, 
stroke, death for all causes, or transfer out of Guadeloupe 
or the end of 2006.
Statistical analysis
The descriptive statistics of patient characteristics were 
performed. The results were expressed as median (IQR: inter-
quartile range) for the continuous variables and by number 
(percentage) for the categorical variables. The subjects were 
divided into two groups according to the occurrence or not of 
events. The chi-square test and the Mann Whitney nonpara-
metric test were used to compare ratios and values between 
patients groups. Correlation between continuous variables 
was tested with Pearson correlation coefﬁ  cient.
Cox proportional hazard modeling was used, to assess the 
risk of CV events or death in patients with the highest values 
of PP, in those without obesity and in those with the dual 
factor high PP – BMI  30 kg/m2. Unadjusted and adjusted 
hazard ratios and 95% conﬁ  dence interval, HR (95% CI) were 
calculated. Adjusted analyses were performed with other 
covariates: gender, age (/10- year increase), time on dialysis Vascular Health and Risk Management 2008:4(6) 1403
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(3 years or 3 years) pre-existing CV complications at 
baseline. Graphical and statistical tests were used to check 
the assumption of proportional hazards.
SPSS V 15.0 statistical software package (SPSS Inc., 
Chicago, IL, USA) was used for data analysis.
A P value  0.05 was considered as signiﬁ  cant.
Results
Overall 80 T2D subjects were included in the study. The 
population was 58% female. The mean (SD) age at baseline 
was 62 (31) years: Tables 1 shows the baseline characteristics 
of the sample of T2D. Of the subjects, 75 (94%) had hyperten-
sion and among them, 84% were treated. Most of the subjects 
received angiotensin-converting enzyme inhibitors or calcium 
channel blockers. Among those receiving antihypertensive 
medications, 5 (7.9 %) had a blood pressure less than 130/80 
mmHg. No signiﬁ  cant difference in frequencies of hyperten-
sion and use of antihypertensive drugs was found between 
subjects with occurrence of CV events and those who died.
Median pulse pressure (IQR) was 75 (63–87) mmHg 
in the overall study sample. There was no significant 
difference in frequencies of high PP in the 3 BMI classes 
(25% for BMI 25, 30% for 25  BMI  30 and 11% 
for BMI  30 kg/m2). Of all, 23.8% of the subjects had 
a high PP, 76% were nonobese, 21% had the dual factor 
high PP – absence of obesity. Four subjects (5%) had a 
morbid obesity and didn’t present outcome during the study 
period.
Pre-existing CV complications were noted in 30 subjects 
(16 coronary events, 18 strokes).
During the three year follow-up period, 23 patients died 
and 13 CV events occurred: 1 nonfatal acute myocardial 
infarction (AMI), 6 fatal AMI, 2 angina (who undergone 
coronary angioplasty), and 3 nonfatal and 1 fatal ischemic 
strokes.
There was no signiﬁ  cant correlation between BMI and PP.
Comparison between groups
Comparison between patient groups without (group1) and 
with (group 2) events (Table 1) didn’t show signiﬁ  cant 
differences for median BMI and median blood pressure 
components.
Table 1 Characteristics of the type 2 diabetic subjects on chronic maintenance hemodialysis (N = 80)
Incidence of cardiovascular events or death
All No Yes P
N = 80 N = 54 N = 26
Quantitative parameters*
Age years 62 (55–70) 61 (53–71) 65 (60–70) 0.28
BMI kg/m2 26 (23–30) 27 (23–31) 26 (22–29) 0.20
Duration of dialysis (years) 2 (1–4) 2 (1–4.2) 2 (0.5–4) 0.97
SBP mm Hg 151 (141–167) 153 (142–165) 156 (142–169) 0.36
DBP mm Hg 78 (70–86) 77 (70–85) 80 (69–86) 0.92
PP mm Hg 74 (63–87) 73 (62–84) 76 (69–90) 0.12
Qualitative parameters **
Gender (women) 46 (57.5) 34 (63.0) 12 (46.2) 0.15
Duration of dialysis 3 years 37 (46.3) 24 (44.4) 13 (50.0) 0.64
High PP 19 (23.8) 10 (18.5) 9 (34.6) 0.11
Hypertension 75 (94) 62 (93) 13 (100) 0.31
Antihypertensive medications 63 (79) 51 (76) 12 (92) 0.19
Absence of obesity 61 (76.3) 38 (70.4) 23 (88.5) 0.07
Morbid obesity 4 (5) 4 (7) 0 (0) 0.15
Dual factor: 17 (21.3) 8 (14.8) 9 (34.6) 0.04
High PP – nonobese
Pre-existing CV events 30 (37.5) 17 (31.5) 13 (50.0) 0.1
Incident CV events 13 (18.3) – 13 (50.0) –
Deaths 23 (28.8) – 23 (88.5) –
Notes: Data are expressed as: *median (IQR), **number (%). High PP  75th percentile of the overall PP values for each gender. Morbid obesity: BMI  40 mm Hg. Hypertension: 
SBP  140 or a DBP  90 mmHg or history of hypertension and current use of antihypertensive medication.
Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; CV events, cardiovascular events.Vascular Health and Risk Management 2008:4(6) 1404
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Nonsigniﬁ  cant trends of high frequencies of PP  75th 
percentile and BMI  30 kg/m2 were found in group 2 
compared to group 1. Frequency of dual variable PP  75th 
percentile – BMI  30 kg/m2 was higher in group 2 (34.6%) 
than in group 1 (14.8%); P = 0.04. Percentages of subjects 
with pre-existing CV events and percentages of those using 
antihypertensive drug therapies were not different between 
groups.
Univariate Cox analysis
Unadjusted hazard ratios (HR) of CV events (fatal and 
nonfatal coronary events and stroke) are presented 
in Table 2. Pre-existing CV complications were not signiﬁ  -
cantly associated with the risk of events. The risk of CV events 
was increased by 2.9–3.5 times with the presence of male 
gender, high PP, or dual variable wide PP – BMI  30 kg/m2. 
Unadjusted HRs of total mortality were signiﬁ  cant for wide 
PP and the dual variable. For the dual variable, the HR of CV 
events was 3.5 (1.2–10.5); P = 0.02 and that of total mortality 
was 2.9 (1.2–6.7); P = 0.01. In both cases, the dual variable 
was the most signiﬁ  cant predictor of events.
Multivariate Cox analysis
In multivariate proportional hazard regression, all models were 
adjusted for age, gender, duration of dialysis, pre-existing 
CV complications and use of antihypertensive medications. 
Hazard ratios of incident CV events were not signiﬁ  cant for 
PP  75th percentile (model 1), BMI  30 kg/m2 (model 2), 
PP  75th percentile and BMI  30 kg/m2 jointly entered in 
the model (model 3) but nearly signiﬁ  cant for the dual vari-
able; 2.7 (0.8–8.3); P = 0.09 (model 4). The hazard ratio of 
total mortality was signiﬁ  cant only for the dual variable wide 
PP – BMI  30 kg/m2: 2.4 (1.1–5.9); P = 0.04.
Discussion
In this three-year follow-up study on Caribbean T2D subjects 
undergoing hemodialysis, we found that combination of a 
wide pulse pressure and body mass index less than 30 kg/m2 
was an independent predictor of total mortality. The results 
also showed that this dual factor had a higher predictive 
value for occurrence of death than both variables separately 
considered. Our ﬁ  ndings highlight those of previous studies 
which reported the reverse epidemiology for obesity in sub-
jects on MHD (Kalantar-Zadeh et al 2005; Kalantar-Zadeh 
2006). Contrary to most of previous studies of patients on 
MHD considering diabetes status as a covariate or a param-
eter of adjustment, our work was conducted in a diabetic 
population. Therefore our results showing nearly signiﬁ  cant 
hazard ratios for PP in predicting cardiovascular events or 
death highlight the need of additional studies on this topic 
in T2D subjects.
In a large sample of subjects free of overt cardiovas-
cular disease from First National Health and Nutrition 
Examination Survey (NHANES I), PP increased with 
increasing of BMI (Domanski et al 2001). This positive 
correlation was not found in our T2D subjects on MHD. 
It is not surprising since an “obesity paradox” has been 
reported in patients with end stage renal disease. In fact, 
lower BMI or serum albumin was identiﬁ  ed as indepen-
dent predictor of wide PP in diabetics and nondiabetics 
on MHD (Kalantar-Zadeh et al 2003).
It is suggested that patients in MHD with normal or 
high normal body weights are faced to malnutrition and 
inﬂ  ammation (Qureshi et al 2002; Liu et al 2004) with the 
latter particularly related to infection (Bellomo et al 2003) In a 
study evaluating the nutritional status in 128 MHD patients by 
subjective nutritional assessment, anthropometric parameters, 
Table 2 Unadjusted hazard ratios for the occurrence of cardiovascular events and deaths in type 2 Diabetic subjects on maintenance 
hemodialysis (N = 80), Guadeloupe, 2003–2006
N Cardiovascular events Death
HR (95% CI) P HR (95% CI) P
Gender (men) 34 3.2 (0.9–10.4) 0.05 1.5 (0.7–3.4) 0.33
Age (/10 years) – 0.9 (0.6–1.6) 0.90 1.3 (0.8–1.9) 0.30
Pre-existing CV events 30 2.2 (0.7–6.6) 0.15 2.0 (0.9–4.6) 0.09
HD duration  3 years 37 1.3 (0.5–4.0) 0.60 1.1 (0.5–2.4) 0.90
Use of antihypertensive medications 63 3.5 (0.5–26.8) 0.22 1.3 (0.5–3.8) 0.63
BMI  30 mmHg 61 3.9 (0.5–30.6) 0.15 3.6 (0.8–15.3) 0.08
PP  75th 19 2.9 (0.9–8.7) 0.05 2.4 (1.1–5.5) 0.04
PP  75th - BMI  30 17 3.5 (1.2–10.5) 0.02 2.9 (1.2–6.7) 0.01
Abbreviations: HR, hazard ratio; CI, conﬁ  dence interval; HD, hemodialysis; BMI, body mass index (cutoff: 30 Kg/m2); PP, pulse pressure (cutoff: 75th percentile by gender).Vascular Health and Risk Management 2008:4(6) 1405
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and several markers of inﬂ  ammation, the authors concluded 
that inﬂ  ammation malnutrition and cardiovascular disease 
factors appeared interrelated, each additionally contributing 
to the high mortality in these patients (Qureshi et al 2002).
Pulse pressure was recognized as a crucial risk 
factor in CV events and mortality in the general popula-
tion (Benetos et al 1997; Glynn et al 2000) and was demon-
strated to increase cardiovascular risk in diabetic and MHD 
patients (Aoun et al 2001). In MHD patients, an elevation of 
systolic blood pressure is generally observed while diastolic 
BP decrease (Saint-Remy 2005) resulting in a high PP. But, 
in a study on 1243 MHD patients in Japan, PP was found as 
a signiﬁ  cant predictor for total mortality only in nondiabetic 
patients (Tozawa al 2002). This blood pressure component 
exhibited, in our T2D subjects, nearly signiﬁ  cant hazard ratio 
for total mortality and appeared as a signiﬁ  cant prognosis 
factor of deaths when it was combined with normal or high 
normal BMI in these subjects.
In a cross-sectional analysis, performed on the same 
Caribbean T2D sample on MHD (Foucan et al 2005), we 
reported that of the four BP components (SBP, DBP, mean 
arterial pressure, and PP), only SBP and PP discriminated 
patients with signiﬁ  cant CV history. In this previous study, 
our results also pointed out a stronger association of pre-
existing CV complications with PP than with SBP.
The present study has some limitations including its very 
small sample size for a MHD population and the possibility 
of misclassiﬁ  cations related to silent myocardial infarction 
occurring frequently in T2D subjects. A survivor bias may 
be associated with the fact that this sample was constituted 
of chronically treated population and was not a cohort of new 
subjects undergoing HD.
But the strength of our study lies in its longitudinal design 
on about 85% of the T2D on MHD from all centers in the 
island avoiding the bias with study populations selected in 
single centers. So, we are allowed to take into account, in 
future guidelines, the results of our report for the management 
of T2D subjects undergoing hemodialysis.
Elevated PP combined with absence of obesity indicates 
high risk of death in T2D patients on MHD. Drugs therapies 
as angiotensin-converting enzyme inhibitors which reduce 
overall mortality (Prisant 2003) and calcium channel block-
ers may reduce aortic pulse wave velocity and pulse pres-
sure (Safar et al 1997, 2004; Sharma et al 2007). While it is 
allowed that some antihypertensive therapy may contribute 
to decrease arterial stiffness and then PP, the management 
of BMI is still a matter for debate (Kalantar-Zadeh 2007). In 
fact, it is difﬁ  cult to recommend weight gaining or obesity 
to improve survival on dialysis patients.
We conclude that, in clinical practice, this dual factor 
may help to identify patients at increase risk of death. We 
think that, in T2D subjects on MHD, a speciﬁ  c manage-
ment should be proposed in nonobese subjects with wide 
PP in order to decrease or prevent the incidence of fatal and 
nonfatal events.
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